Nassim Anjidani - Medical Department, Orchid Pharmed Company

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 32 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effects of Age and Gender on Immunogenicity and Reactogenicity of SpikoGen Recombinant Spike Protein Vaccine: a Post-Hoc Analysis

Nassim Anjidani,Ramin Shahpari,Hamidreza Kafi,Nikolai Petrovsky,Saghar Barati

Scientific Reports（2024）

引用0浏览0WOSNATURE引用

Comparative Immunogenicity and Safety of SpikoGen®, a Recombinant SARS-CoV-2 Spike Protein Vaccine in Children and Young Adults: an Immuno-Bridging Clinical Trial

Payam Tabarsi,Setareh Mamishi,Nassim Anjidani,Ramin Shahpari,Hamidreza Kafi,Newsha Fallah,Babak Yazdani,Ali Ebrahimi,Khashayar Roshanzamir, Hamidreza Ebrahimi, Soudabeh Oveisi,Adele Soltani,Nikolai Petrovsky,Saghar Barati

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

引用0浏览0WOS引用

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

Payam Tabarsi,Nassim Anjidani,Ramin Shahpari,Masoud Mardani,Araz Sabzvari,Babak Yazdani,Hamidreza Kafi,Newsha Fallah,Ali Ebrahimi,Ali Taheri,Nikolai Petrovsky,Saghar Barati

Clin Microbiol Infect（2023）

引用16浏览0WOS引用

Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study

Abdorreza Naser Moghadasi,Fereshteh Ashtari,Seyed Mohammad Baghbanian,Vahid Shaygannejad,Nassim Anjidani,Fereshteh Ghadiri,Behnaz Sedighi,Morteza Saeidi,Hamed Amirifard,Hormoz Ayromlou,Nahid Beladi Moghadam, Mohammad Bagher Ranjbar,Masoume Nazeri,Zahra Niknam,Fardin Faraji, Afsaneh Afsorde,Mohammad Ali Sahraian

Archives of iranian medicineno. 11 (2023): 647-653

引用0浏览0WOS引用

Evaluating the Safety and Effectiveness of PegaGen® (pegfilgrastim) for the Prevention of Chemotherapy-Induced Febrile Neutropenia: a Post-Marketing Surveillance Study

Jenabian Arash,Ehsanpour Ali,Mortazavizadeh Seyed Mohammad Reza,Raafat Jahangir,Razavi Mohsen,Khosravi Adnan,Seifi Sharareh,Salimi Babak,Anjidani Nassim,Kafi Hamidreza

Supportive care in cancer（2022）

引用0浏览0WOS引用

P364 Comparison of Two Treatment Strategies in IBD: Biosimilar Adalimumab (cinnora®) in Monotherapy and in Combination with Azathioprine

F. AlborziAvanaki, N. Moghbel,N. Aletaha,N. E. Daryani,M. J. Farahvash, A. Miroliaii, N. Shayegan,N. Anjidani

Journal of Crohn s and Colitisno. Supplement_1 (2022): i370-i371

引用1浏览0引用

Immunogenicity and Safety of SpikoGen®, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-Arm Clinical Trial

Mohsen Nafar,Narges Mostafaloo,Ahmad Firouzan,Fatemeh Poorrezagholi,Fariba Samadian,Nooshin Dalili,Saghar Barati,Nassim Anjidani,Hamidreza Kafi,Ramin Shahpari, Mahdiye Bayat,Soha Kianipour,Shiva Samavat

Clinical Therapeuticsno. 12 (2022): 1566-1576

引用2浏览0WOS引用

Immunogenicity and safety of SpikoGen (R), an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial

Payam Tabarsi,Nassim Anjidani,Ramin Shahpari,Khashayar Roshanzamir,Newsha Fallah,Greiciely Andre,Nikolai Petrovsky,Saghar Barati

IMMUNOLOGY（2022）

引用17浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn